Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Agent Capital is a healthcare venture capital firm based in Waltham, Massachusetts. Founded to invest in novel therapeutics, the firm focuses on addressing unmet patient needs. They engage in direct equity investments across all stages of development, partnering with scientists and entrepreneurs to advance healthcare innovations.
Agent Capital invests in therapeutic areas with high unmet medical needs, including rare diseases, oncology, neurology, and immunology. They participate in financing rounds from pre-seed to growth equity, supporting both early-stage and later-stage companies. Their investment strategy encompasses preclinical, clinical, and commercial stages of development.
Notable portfolio companies include: Dice Therapeutics: Acquired by Lilly for $2.4 billion; Freenome: Pioneering a multiomics platform for early cancer detection; ImCheck Therapeutics: Acquired by Ipsen for €1 billion; Interius BioTherapeutics: Acquired by Kite for $350 million; Alveus Therapeutics: Recently raised $197 million in Series A financing; Cerevance: Developing treatments for CNS disorders.
Email info@agentcapital.com with your deck to pitch Agent Capital.
Agent Capital often leads financing rounds, particularly in early-stage investments, to provide substantial support to portfolio companies.
The firm actively participates in follow-on investments to support the growth of their portfolio companies through various stages of development.
Specific fund size details are not disclosed, but Agent Capital engages in a wide range of financing rounds, indicating significant capital availability.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.